15 Μαρ Inadequate responses to current drug treatments means that new therapies for neuropathic pain are required
Necessary NeuPSIG revisions made for neuropathic pain treatment recommendations Background New drug treatments, clinical trials, and standards of quality for assessment of evidence justify an update of evidence-based recommendations for the pharmacological treatment of neuropathic pain. Using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE), we...